Later on, analysis of intracellular G6PD activity in various cancer cell lines, such as human cervical carcinomas, esophageal carcinomas, hepatomas, lung adenocarcinomas, and colon adenocarcinomas, revealed that G6PD was particularly overexpressed in human esophageal cancer cell lines (30). This evidence concerns the gene G6PD and colon adenocarcinoma.